✦ LIBER ✦

Can a fast bone loss in osteoporotic patients be stopped with vitamin D metabolites?

✍ Scribed by M. A. Dambacher; C. Merlin; M. Neff; M. Kranien; R. Kissliag

Book ID: 105599432
Publisher: Springer-Verlag
Year: 1996
Tongue: English
Weight: 125 KB
Volume: 6
Category: Article
ISSN: 0937-941X
DOI: 10.1007/bf02500503

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Can the fast bone loss in osteoporotic a

Can the fast bone loss in osteoporotic and osteopenic patients be stopped with active vitamin D metabolites?

✍ M. A. Dambacher; M. Kranich; E. Schacht; M. Neff 📂 Article 📅 1997 🏛 Springer 🌐 English ⚖ 481 KB

F161 Can the fast bone loss in osteoporo

F161 Can the fast bone loss in osteoporotic patients be stopped with vitamin D metabolites as an alternative to estrogens?

✍ M.A. Dambacher; C. Merlin; M. Neff 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 117 KB

Can vitamin D3supplementation prevent bo

Can vitamin D3supplementation prevent bone loss in persons with MS? A placebo-controlled trial

✍ Linn H. Steffensen; Lone Jørgensen; Bjørn Straume; Svein Ivar Mellgren; Margitta 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 223 KB

A new active vitamin D analog, ED-71, ca

A new active vitamin D analog, ED-71, causes increase in bone mass with preferential effects on bone in osteoporotic patients

✍ N. Kubodera; N. Tsuji; Y. Uchiyama; K. Endo 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB

## Abstract As a candidate for active vitamin D analogs that have selective effects on bone, 1α,25‐dihydroxy‐2β‐(3‐hydroxypropoxy)vitamin D3 (ED‐71) has been synthesized and is currently under clinical trials. In ovariectomized rat model for osteoporosis, ED‐71 caused an increase bone mass at the l